Vaginal candidosis;Infekcje drożdżakowe dróg rodnych

Mikologia Lekarska

Volumn 10, Issue 1, 2003, Pages 51-55

  Hryncewicz Gwóźdź, Anita ^a   Plomer Niezgoda, Ewa ^a   Baran, Eugeniusz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Candida sp.; Treatment; Vulvovaginal candidosis

Indexed keywords

PYRROLE;

ANTIFUNGAL ACTIVITY; CANDIDA; FREQUENCY ANALYSIS; HUMAN; RECURRENT INFECTION; REVIEW; TREATMENT FAILURE; VAGINA CANDIDIASIS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS;

EID: 0037239564     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Jovanovic R., Congema E., Nguyen H.T.: Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. J. Reprod. Med., 1991, 36, 593-597.
2. Światłowska-Gȯrna B.: Współczesne lecznictwo mikologiczne. Post. Dermatol., 1993, 10, 475-501.
3. Czaika V., Tietz H.J., Schmalreck A. i wsp.: Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy. Mycoses, 2000, 43 (Suppl. 2), 45-50.
4. Tobin J.M., Loo P., Granger S.E.: Treatment of vaginal candidosis: a comperative study of the efficacy and acceptability of itraconazole andclotrimazole. Genitourin Med., 1992, 68, 36-38.
5. Stein G.E., Mummaw N.: Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob. Agents Chemother., 1993, 37, 89-92.
6. Woolley P.D., Higgins S.P.: Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. Br. J. Clin. Pract., 1995, 49, 65-66.
7. Mikamo H., Kawazoe K., Sato Y., Hayasaki Y, Tamaya T.: Comparative study on the effectivnes of antifungal agents in different regimens against vaginal candidiasis. Chemotherapy, 1998, 44, 364-368.
8. Daneshmend T.K.: Ketoconazole - cyclosporin interaction. Lancet, 1982, 2, 1342-1343.
9. Katz H.J.: Guide to adverse treatment interaction for skin hair and nail disorders. Lippincott-Raven, Philadelphia 1998.
10. Baran E.: Interakcje leków przeciwgrzybiczych stosowanych ogólnie z innymi grupami lekȯw. Mikol. Lek., 2001, 8, 171-174.
11. Spinillo A., Capuzzo E., Gulminetti R. i wsp.: Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am. J. Obstet. Gynecol., 1997, 176, 138-141.
12. Sobel J.D.: Treatment of vaginal Candida infections. Expert Opin. Pharmacother., 2002, 3, 1059-1065.
13. MacNeill C., Carey J.C.: Recurrent vulvovaginal candidiasis. Curr. Womens Health Rep., 2001, 1, 31-35.
14. Ringdahl E.N.: Treatment of recurrent vulvovaginal candidiasis. Am. Fam. Physician, 2000, 61, 3306-3317.
15. Maleszka R., Baran E.: Lecznictwo mikologiczne w koṅcu dwudziestego wieku. Mikol. Lek., 2000, 7, 47-55.
16. Orozco A.S., Higginbotham L.M., Hitchcock C.A. i wsp.: Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother., 1998, 42, 2645-2649.
17. Horowitz B.J.: Mycotic vulvovaginitis: a broad overview. Am. J. Obstet. Gynecol., 1991, 165, 1188-1192.
18. Van Cutsem J.: Itraconazole and therapy of fungal infections. Curr. Probl. Dermatol., 1996, 24, 194-202.
19. Krajewska-Kułak E., Niczyporuk W.: Dermatofitozy imituja̧ce inne schorzenia skȯry. Mikol. Lek., 1999, 6, 107-111.
20. Reed B.: Risk factors for Candida vulvovaginitis. Obstet. Gynecol. Surv., 1992, 47, 551-560.
21. Bohannon N.J.: Treatment of vulvovaginal candidiasis in patients with diabetes. Diabetes Care, 1998, 21, 451-456.
22. Sobel J.D., Faro S., Force R.W.: Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol., 1998, 178, 203-211.
23. Sobel J.D.: Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis., 1992, 14 (Suppl. 1), S148-S153.
24. Dun E.: Antifungal resistance in yeasts vaginitis. Yale J. Biol. Med., 1999, 72, 281-285.
25. Spinillo A., Pizzoli G., Colonna L. i wsp.: Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal cadidiasis. Obsts. Gynecol., 1993, 81, 721-727.
26. Creatas G.C., Charalambidis V.M., Zagotzidou E.H., Anthopolou H.N., Michailidis D. C., Aravantinos D.I.: Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole. 1993, 15, 662-671.
27. Spinillo A., Colonna L., Piazzi G., Baltaro F., Monaco A, Ferrari A: Mantaging recurrent vulvovaginal candidiasis. Intermittent prevention with itraconazole. J. Reprod. Med., 1997, 42, 83-87.
28. Guaschino S., De Seta F., Sartore A.: Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol., 2001, 184, 598-602.